Blog
RSS FeedPosted by Michael Wonder on 10 Aug 2020
Can multi-criteria decision analysis be implemented into real world drug decision-making processes? A Canadian provincial experience
7 August 2020 - This paper describes the implementation of multi-criteria decision analysis into a Canadian public drug reimbursement decision-making process, ...
Posted by Michael Wonder on 10 Aug 2020
Return some excess drug revenues to employers, CLHIA says in submission to PMPRB
10 August 2020 - In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and ...
Posted by Michael Wonder on 10 Aug 2020
B.C. family nearing finish in race to raise $2.8 million to treat baby's rare disease
8 August 2020 - Parents hope funds will pay for expensive therapy not approved in Canada for type 1 spinal muscular ...
Posted by Michael Wonder on 07 Aug 2020
Catalyst Pharmaceuticals’ Firdapse (amifampridine phosphate) receives marketing approval in Canada for patients with LEMS
6 August 2020 - Catalyst Pharmaceuticals today announced that Canada’s national health care regulatory agency, Health Canada, has approved the ...
Posted by Michael Wonder on 05 Aug 2020
Canada inks deals with Pfizer, Moderna for coronavirus vaccine candidates
5 August 2020 - The Canadian government has signed new deals with pharmaceutical firms Pfizer and Moderna to secure millions ...
Posted by Michael Wonder on 04 Aug 2020
Janssen announces Health Canada approval of Darzalex SC, a new subcutaneous formulation for the treatment of patients with multiple myeloma
4 August 2020 - Darzalex SC reduces administration time from hours to minutes and demonstrates consistent efficacy with a reduction in ...
Posted by Michael Wonder on 04 Aug 2020
Innovative Medicines Canada responds to the revised draft PMPRB Guidelines consultation
4 August 2020 - The Patented Medicine Prices Review Board's revised Guidelines will result in patients losing access to innovative ...
Posted by Michael Wonder on 30 Jul 2020
Health Canada Approves Brivlera (brivaracetam) to treat partial-onset seizures in paediatric epilepsy patients
29 July 2020 - Health Canada's approval of Brivlera provides paediatric epilepsy patients with a treatment option which can be initiated ...
Posted by Michael Wonder on 28 Jul 2020
CADTH publishes final recommendation for a new combination product for HIV infection
24 July 2020 - Cabenuva (cabotegravir and rilpivirine extended release injectable suspensions) is indicated as a complete regimen for the treatment ...
Posted by Michael Wonder on 28 Jul 2020
Health Canada grants marketing authorisation with conditions for Gilead's Veklury (remdesivir) for the treatment of coronavirus disease 2019 (COVID-19)
28 July 2020 - Veklury is the first approved treatment option for COVID-19 in Canada. ...
Posted by Michael Wonder on 27 Jul 2020
CADTH posts final recommendation for Aimovig
26 July 2020 - Final recommendation informed by input from Migraine Canada and Migraine Quebec. ...
Posted by Michael Wonder on 26 Jul 2020
'I need something to move forward,' says Edmonton mom waiting for approval for son's life saving treatment
24 July 2020 - The family of a little boy in need of a $3 million treatment says they have ...
Posted by Michael Wonder on 23 Jul 2020
CADTH publishes final recommendation for Mayzent
23 July 2020 - The recommendation relates to the use of siponomid for the treatment of patients with secondary progressive multiple ...
Posted by Michael Wonder on 23 Jul 2020
Spravato (esketamine) nasal spray is available for Canadian patients
22 July 2020 - A new anti-depressant with a novel mechanism of action to treat major depressive disorder in adults. ...
Posted by Michael Wonder on 22 Jul 2020
Pandemic creating potential for drug shortages that Canada isn't equipped to deal with
22 July 2020 - Canada needs to become self-reliant in developing and supplying its own critical drugs, vaccines. ...